New investor presentation from Medical Facilities Corp. (TSX: DR), updated with first half 2020 results. Medical Facilities Corporation, in partnership with physicians, owns a diverse portfolio of highly rated, high-quality surgical facilities in the United States. For more information, please visit www.medicalfacilitiescorp.ca.
2. Forward-Looking Statements
This presentation may contain forward-looking statements within the meaning of certain securities laws,
including the “safe harbour” provisions of the Securities Act (Ontario) and other provincial securities law in
Canada. These forward-looking statements include, among others, statements with respect to our objectives,
goals and strategies to achieve those objectives and goals, as well as statements with respect to our beliefs,
plans, objectives, expectations, anticipations, estimates and intentions. The words “may”, “will”, “could”,
“should”, “would”, “suspect”, “outlook”, “believe”, “plan”, “anticipate”, “estimate”, “expect”, “intend”, “forecast”,
“objective” and “continue” (or the negative thereof), and words and expressions of similar import, are intended
to identify forward-looking statements. Any such statements are subject to risks and uncertainties that could
cause actual results to differ materially from those projected in these forward-looking statements. For more
information on the risk factors related to these forward-looking statements, please refer to the management’s
discussion and analysis, annual information form and ongoing quarterly filings of Medical Facilities Corporation
available on SEDAR at www.sedar.com.
2
3. 3
* Figures have been modified to reflect continuing operations only,
which is defined as consolidated operations excluding Unity Medical
and Surgical Hospital and RRI Mishawaka Hospital, LP. These
entities are treated as discontinued operations in the financial
results for the fourth quarter and year ended December 31, 2019.
** As at June 30, 2020.
US$398.1
million
2019 Revenue*
US$96.2
million
2019 Adj. EBITDA*
180
Physician Partners**
US$44.5
million
2019 Income from
Operations*
In partnership with
physicians, MFC
owns a diverse
portfolio of highly
rated, high-quality
surgical facilities in
the United States.
MFC Overview
4. STRONG
PARTNERS
• Direct Physician
involvement in facility
management, resulting
in superior processes
and efficiencies
• MFC Nueterra, a joint
venture with NueHealth,
LLC, provides
operational support,
procurement benefits
and growth opportunities
4
5. BEST IN
CLASS
Higher patient satisfaction
ratings resulting from higher
quality of care
HCAHPS
Survey*
* Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS), a survey
conducted by the U.S. Department of Health and Human Services, is the first national, standardized
and publicly reported survey of patients’ perspectives of hospital experiences, based on ten important
hospital quality topics. Ratings presented above are as of January 2020.
of patients would
definitely
recommend MFC
hospitals
89%
72%
U.S. average
6. DIVERSIFIED
Medical Facilities Corp. MFC Nueterra
• Controlling interest in 4
specialty surgical hospitals
located in Arkansas,
Oklahoma, and South
Dakota, and an ASC1
located in California
• Non-controlling interest in a
specialty surgical hospital
in Indiana
• Controlling interest in 5
ASCs located in Michigan,
Missouri, Nebraska, Ohio,
and Pennsylvania
• Non-controlling interest in
an ASC in Missouri
Portfolio
comprised of
high-quality
surgical facilities
in 9 U.S. states
1 ASC stands for ambulatory surgery center 6
8. Favourable Payor Mix
51%
34%
15%
Private Insurance Medicare/Medicaid Other
38%
34%
28%
Private Insurance Medicare/Medicaid Other
Source: Centers for Medicare & Medicaid Services, National Health Expenditure Projections
2019 MFC Facility Service Revenue 2019 U.S. Healthcare System Revenue
8
9. The U.S. Healthcare Landscape
Facility type Number Services MFC’s position
Acute Care Hospital Approx. 5,500
General medicine and
surgery, including emergency
and maternity care, open
24/7
Specialty Surgical Hospital <300 physician-owned
Scheduled elective
procedures (e.g. orthopedics,
neurosurgery, pain
management)
Owns 4 in conjunction with
physician partners
Ambulatory Surgery Center Approx. 5,500
Scheduled elective
procedures;
Day surgery only
Owns 6 in conjunction with
physician partners
9
10. 1010
Expand capacity of
existing facilities
Diversify our revenue
base
Leverage our MFC
Nueterra Partnership
• Recruit new physicians
• Enhance facilities and
equipment through capital
investment
• Add ancillary services
• i.e. urgent care clinics
• De novo opportunities
• Acquisitions
FOCUSED ON
GROWTH
11. Disciplined Approach to Acquisitions
Strict
acquisition
criteria
Accretion, with growth available from a strong
provider base and opportunities for operating
enhancements
High quality and optimum clinical outcomes
Continued strong earnings and
opportunity for growth
1
2
3
11
12. EBITDA, cash distributions and payout ratio are non-IFRS financial measures. Please refer to “Non-IFRS Financial Measures” and “Reconciliation of Non-IFRS
Financial Measures” sections in the Management’s Discussion and Analysis of Consolidated Financial Condition and Results of Operations for the three and six
months ended June 30, 2020.
H1 2020 Highlights
12
(US$ millions, except where noted otherwise) Q2 2020 Q2 2019 Change % H1 2020 H1 2019 Change %
Facility service revenue 67.7 94.2 -28.2% 160.4 187.6 -14.5%
Government stimulus income 21.1 -- +100% 21.1 -- +100%
Total revenue and other income 88.8 94.2 -5.8% 181.6 187.6 -3.2%
Income from operations 17.6 12.8 +37.7% 28.6 25.6 +11.8%
EBITDA 24.6 20.5 +19.9% 42.7 41.2 +3.6%
EBITDA Margin 27.7% 21.8% +27.1% 23.5% 22.0% -6.8%
Cash available for distributions
(C$ millions)
8.2 4.9 +68.8%
17.1 10.1 +68.4%
Payout Ratio 26.5% 179.0% -85.2% 25.5% 172.4% -85.2%
13. Well Resourced for Growth
$79.8
million
Cash& Cash
Equivalents
0.78
Net Debt* /
Equity
1.43
Net Debt* /
EBITDA
1.7x
Current Ratio
As at June 30, 2020 13
* inclusive of lease liabilities per IFRS 16
14. Investment Highlights
14
• Large, growing & fragmented market for outpatient services
• Diverse portfolio of highly rated, high quality facilities
• Scalable platform for growth – organically and via acquisitions
• Experienced, entrepreneurial management team
• Competitive dividend
15. Capital Markets Profile
As at September 30, 2020
15
Stock Symbol: TSX: DR
Shares Outstanding: 31.1 million
Price: $4.37
Market Capitalization: $135.72 million
Annualized Distribution (per share): $0.28
Current Yield: 6.41%
*All figures in Canadian dollars
16. EXPERIENCED
David N. T. Watson
Chief Financial Officer
Formerly: Clearway Pain Solutions,
National Surgical Hospitals
Robert O. Horrar
President and Chief Executive Officer
Formerly: Community Health Systems,
Humana
James D. Rolfe
Chief Development Officer
Formerly: VMG Health, Community Health
Systems
John Schario
Chief Operating Officer
Formerly: Nueterra Healthcare
Management, Mountain States Health
Alliance
16
17. To learn more, contact:
Trevor Heisler
NATIONAL Capital Markets
416-848-1434
theisler@national.ca